Cargando…
The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis
BACKGROUND: Rosacea is a common chronic skin condition that manifests as recurrent inflammatory lesions. Long-term treatment is required to control symptoms and disease progression, with topical treatments being the first-line choice. Ivermectin 1 % cream is a new once-daily (QD) topical treatment f...
Autores principales: | Siddiqui, Kashif, Gold, Linda Stein, Gill, Japinder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956638/ https://www.ncbi.nlm.nih.gov/pubmed/27504249 http://dx.doi.org/10.1186/s40064-016-2819-8 |
Ejemplares similares
-
Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States
por: Taieb, Alain, et al.
Publicado: (2016) -
Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments
por: Steinhoff, Martin, et al.
Publicado: (2016) -
Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations
por: Ebbelaar, Chiel Cristiano F., et al.
Publicado: (2018) -
Topical Metronidazole Versus Ivermectin for Low-density Demodex Rosacea: A Rater-blinded, Randomized, Split-face Trial
por: YEH, Marvin Chia-Han, et al.
Publicado: (2022) -
New developments in the treatment of rosacea – role of once-daily ivermectin cream
por: Cardwell, Leah A, et al.
Publicado: (2016)